Dr. Mirella Díaz-Santos has a personal fight to end Alzheimer’s Disease. Her grandmother was diagnosed with Alzheimer’s when Díaz-Santos was in school. “I needed to know more about how this ‘disease’ can change someone who you love so much. How can it change it completely?” Díaz-Santos said. Díaz-Santos is an assistant professor in residence at University of California at Los Angeles (UCLA) in the department of neurology and psychiatry. She’s also the director of research of the Hispanic Neuropsychiatric Center of Excellence at the Semel Institute for Neuroscience and Human Behavior and is involved with the Women’s Alzheimer’s Movement to bring awareness to Alzheimer’s within the Latino community. Although she’s experienced bias and discrimination ...
Maria Maldonado knows what it’s like to experience the tragedy of COVID-19. She lost five family members to the virus in the past year, including her mother. “It was just a tidal wave. And it was just very hard for us to go through something so tragic, back to back. It was a very difficult time,” Maldonado said. When the vaccine became available for adults, Maldonado couldn’t wait to get one. “I was not hesitant at all. Why? Because I trust science. They developed it fast, but they still took the protocols and the safety measures that they had to take,” Maldonado said. Once the vaccine was available for children ages 5 to 11, Maldonado got her 9-year-old son Jacob vaccinated. She hopes that other Latino parents will vaccinate their children and help protect ...
Like many Latino students, Donají Stelzig was unsure if she should pursue a PhD. She was intimated by the barriers and didn’t think she was capable of doing it, especially since she already had a full-time job and family. But after attending the Éxito! Latino Cancer Research Leadership Training at UT Health San Antonio, the researchers and scholars she met encouraged her to apply and followed up with her even when she was doubtful. Now, Stelzig has a doctoral degree and is a visiting assistant professor and lecturer at the University of Houston, where she also directs the Community Health Worker Training Center at the Honors College. She’s grateful for the Éxito! experience and how it helped her build a network to succeed throughout her career.
Learning About ...
Growing up as a gay, Latino man in the 1990s, Dr. Philip Ponce saw the devastating impact of HIV and AIDS. It pushed him to a medical career. “A lot of people in my community were dying of AIDS. I knew I wanted to work with other gay men, and I knew I wanted to take care of people with HIV,” Dr. Ponce said. Dr. Ponce is the Medical Director at Kind Clinic San Antonio, a clinic that provides sexual health services such as HIV testing and treatment, STI testing and treatment, access to HIV prevention medication known as PrEP (pre-exposure prophylaxis) and PEP (post-exposure prophylaxis) and gender-affirming care. He’s also an assistant professor of infectious diseases at UT Health San Antonio and director of transplant infectious diseases at the University Transplant ...
Jeraldine Ortiz knows that breast cancer is tough for Latinas. Breast cancer is the top cause of Latina death. This stems from cultural barriers to care, low screening rates, and low participation in clinical trials studies trying to find better treatments. This is why Ortiz, when diagnosed with breast cancer, volunteered for a clinical trial. Today, after more than 15 years as a cancer survivor, Ortiz said she strongly believes her participation in a clinical trial at UT Health San Antonio helped her get better treatment and better quality of life in her post-cancer journey. “Clinical trials give the opportunity to better treatment for all populations," Ortiz said. "We have a better future."
Ortiz Chooses a Breast Cancer Clinical Trial
In 2006, Ortiz was diagnosed with ...
Jeraldine Ortiz sabe que el cáncer de seno es difícil para las latinas. El cáncer de seno es la causa principal de muerte entre latinas. Esto se debe a las barreras culturales para la atención de salud, las bajas tasas de detección temprana y la baja participación en los estudios clínicos que buscan encontrar mejores tratamientos. Esta es la razón por la que Ortiz, cuando fue diagnosticada con cáncer de seno, decidió participar en un estudio clínico. Hoy, después de más de 15 años como sobreviviente de cáncer, Ortiz dijo que cree firmemente que su participación en un estudio clínico de UT Health San Antonio la ayudó a obtener un mejor tratamiento y una mejor calidad de vida después del cáncer. "Los estudios clínicos dan la oportunidad de un mejor ...
Dr. Melawhy Garcia wanted to elevate her work to improve health among Latinos in California by applying for PhD programs, but she wasn’t sure about it. She wanted to hear from experienced faculty and scholars about what the process would be like. That’s why she attended the Éxito! Latino Cancer Research Leadership Training at UT Health San Antonio. “I actually knew some of the faculty presenting at [Éxito!], so I definitely wanted to hear from them and see what their journey was like going through a PhD program,” Garcia said. Éxito! helped Garcia apply to PhD programs and get accepted to a joint Doctoral Program in Public Health from the University of California, San Diego and San Diego State University. Now, Garcia is an assistant professor in the Department of ...
Breast cancer is the top cause of death for Latinas. But Alma Lopez has been a breast cancer survivor for more than 15 years. She believes participating in a clinical trial at UT Health San Antonio helped her get better treatment and better long-term health in her survivorship journey. “Clinical trials are great for finding new treatments that help people,” Lopez said. “And it helps the scientists. It gives opportunity to better medication for all populations. It builds a better future.”
Lopez Chooses a Breast Cancer Clinical Trial
About 15 years ago, Lopez was diagnosed with breast cancer. Lopez began weighing her treatment options. At first, she had doubts about whether to volunteer for a clinical trial. She thought it might take too much time, or cause ...
El cáncer de Seno es la causa principal de muerte en las latinas. Pero Alma López ha sido una sobreviviente de cáncer de seno por más de 15 años. Ella cree que su participación en un estudio clínico de UT Health San Antonio la ayudó a tener un mejor tratamiento y a largo plazo una mejor salud en su camino de supervivencia. "Los estudios clínicos pueden encontrar tratamientos nuevos que ayudan a las personas", dijo López. "Y ayudan a los científicos. Ofrecen la oportunidad de tratamientos mejores para todas las poblaciones. Construyen un futuro mejor".
López Decidió Participar en un Estudio Clínico de Cáncer de Seno
Aproximadamente hace 15 años, López fue diagnosticada con cáncer de seno. López comenzó a considerar sus opciones de tratamiento. Al ...
